Provident Investment Management, Inc. Aerie Pharmaceuticals Inc Transaction History

Provident Investment Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$17.72 - $25.1 $6.58 Million - $9.32 Million	-371,174 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$18.41 - $28.0 $591,771 - $900,032	-32,144 Reduced 7.97%	371,174 $7.13 Million
Q2 2019 Aug 08, 2019	BUY	$28.97 - $48.21 $240,393 - $400,046	8,298 Added 2.1%	403,318 $11.9 Million
Q1 2019 May 13, 2019	BUY	$36.32 - $49.25 $4.65 Million - $6.3 Million	127,953 Added 47.91%	395,020 $18.8 Million
Q4 2018 Feb 11, 2019	BUY	$33.0 - $60.04 $170,742 - $310,646	5,174 Added 1.98%	267,067 $9.64 Million
Q3 2018 Nov 13, 2018	BUY	$56.15 - $73.9 $14.7 Million - $19.4 Million	261,893 New	261,893 $16.1 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Provident Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Provident Investment Management, Inc. with notifications on news.